Page last updated: 2024-09-05

varenicline and Genetic Predisposition

varenicline has been researched along with Genetic Predisposition in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dilley, JE; Filosa, NJ; Fischer, SM; Froehlich, JC; Nicholson, ER; Rademacher, LC; Smith, TN	1
Nelson, R; Pumariega, AJ; Rotenberg, L	1
Benowitz, NL	1

Reviews

1 review(s) available for varenicline and Genetic Predisposition

Article	Year
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4 Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American; Bupropion; Cotinine; Cues; Cytochrome P-450 CYP2A6; Drug Tolerance; Genetic Predisposition to Disease; Harm Reduction; Humans; Menthol; Mixed Function Oxygenases; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Reinforcement, Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline; White People	2008

Article

Year

Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.

Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American; Bupropion; Cotinine; Cues; Cytochrome P-450 CYP2A6; Drug Tolerance; Genetic Predisposition to Disease; Harm Reduction; Humans; Menthol; Mixed Function Oxygenases; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Reinforcement, Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline; White People

2008

Other Studies

2 other study(ies) available for varenicline and Genetic Predisposition

Article	Year
A Combination of Naltrexone + Varenicline Retards the Expression of a Genetic Predisposition Toward High Alcohol Drinking. Alcoholism, clinical and experimental research, 2017, Volume: 41, Issue:3 Topics: Alcohol Drinking; Animals; Drug Therapy, Combination; Genetic Predisposition to Disease; Male; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Rats; Varenicline	2017
Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression. CNS spectrums, 2008, Volume: 13, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Benzazepines; Bipolar Disorder; Depressive Disorder; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotherapy; Quinolones; Quinoxalines; Smoking Cessation; Stress, Psychological; Varenicline	2008

Article

Year

A Combination of Naltrexone + Varenicline Retards the Expression of a Genetic Predisposition Toward High Alcohol Drinking.

Alcoholism, clinical and experimental research, 2017, Volume: 41, Issue:3

Topics: Alcohol Drinking; Animals; Drug Therapy, Combination; Genetic Predisposition to Disease; Male; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Rats; Varenicline

2017

Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression.

CNS spectrums, 2008, Volume: 13, Issue:6

Topics: Antipsychotic Agents; Aripiprazole; Benzazepines; Bipolar Disorder; Depressive Disorder; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotherapy; Quinolones; Quinoxalines; Smoking Cessation; Stress, Psychological; Varenicline

2008